Skip to main content
Top
Published in: Urolithiasis 1/2016

01-02-2016 | Invited Review

Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease

Author: W. G. Robertson

Published in: Urolithiasis | Issue 1/2016

Login to get access

Abstract

This review describes the various dietary regimens that have been used to advise patients on how to prevent the recurrence of their calcium-containing kidney stones. The conclusion is that although there is some general advice that may be useful to many patients, it is more efficacious to screen each patient individually to identify his/her main urinary, metabolic, nutritional, environmental, and lifestyle risk factors for stone-formation and then tailor specific advice for that particular patient based on the findings from these investigations. If the patient can be motivated to adhere strictly to this conservative approach to the prophylactic management of their stone problem over a long time period, then it is possible to prevent them from forming further stones. This approach to stone management is considerably less expensive than any of the procedures currently available for stone removal or disintegration. In the UK, for each new stone episode prevented by this conservative approach to prophylaxis it is calculated to save the Health Authority concerned around £2000 for every patient treated successfully. In the long term, this accumulates to a major saving within each hospital budget if most stone patients can be prevented from forming further stones and when the savings are totalled up country-wide saves the National Exchequer considerable sums in unclaimed Sick Pay and industry a significant number of manpower days which would otherwise be lost from work. It is also of immense relief and benefit to the patients not to have to suffer the discomfort and inconvenience of further stone episodes.
Literature
1.
go back to reference Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef
2.
go back to reference De SK, Liu X, Minga M (2014) Changing trends in the American diet and the rising prevalence of kidney stones. Urology 84:1030–1033PubMedCrossRef De SK, Liu X, Minga M (2014) Changing trends in the American diet and the rising prevalence of kidney stones. Urology 84:1030–1033PubMedCrossRef
3.
4.
go back to reference Turney BW, Reynard JM, Noble JG, Keoghane SR (2012) Trends in urological stone disease. BJU Int 109:1082–1087PubMedCrossRef Turney BW, Reynard JM, Noble JG, Keoghane SR (2012) Trends in urological stone disease. BJU Int 109:1082–1087PubMedCrossRef
5.
go back to reference Robertson WG (2012) General and specific dietary advice for the prevention of stone recurrence. In: Talati JJ, Tiselius H-G, Albala DM, Ye Z (eds) Urolithiasis—basic science and clinical practice. Springer, London, pp 709–720 Robertson WG (2012) General and specific dietary advice for the prevention of stone recurrence. In: Talati JJ, Tiselius H-G, Albala DM, Ye Z (eds) Urolithiasis—basic science and clinical practice. Springer, London, pp 709–720
6.
go back to reference Robertson WG, Peacock M (1985) The origin of metabolic abnormalities in primary calcium stone disease—natural or unnatural selection? In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York, pp 287–290CrossRef Robertson WG, Peacock M (1985) The origin of metabolic abnormalities in primary calcium stone disease—natural or unnatural selection? In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York, pp 287–290CrossRef
7.
go back to reference Andersen DA (1973) Environmental factors in the aetiology of urolithiasis. In: Cifuentes Delatte L, Rapado A, Hodgkinson A (eds) Urinary calculi. Karger, Basael, pp 130–144 Andersen DA (1973) Environmental factors in the aetiology of urolithiasis. In: Cifuentes Delatte L, Rapado A, Hodgkinson A (eds) Urinary calculi. Karger, Basael, pp 130–144
8.
go back to reference Robertson WG, Peacock M, Hodgkinson A (1979) The effect of dietary changes on the incidence of urinary calculi in the UK between 1958 and 1976. J Chron Dis 32:469–476PubMedCrossRef Robertson WG, Peacock M, Hodgkinson A (1979) The effect of dietary changes on the incidence of urinary calculi in the UK between 1958 and 1976. J Chron Dis 32:469–476PubMedCrossRef
9.
go back to reference Robertson WG (1987) Diet and calcium stones. Miner Electrolyte Metab 13:228–234PubMed Robertson WG (1987) Diet and calcium stones. Miner Electrolyte Metab 13:228–234PubMed
10.
go back to reference Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. New Engl J Med 328:833–838PubMedCrossRef Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. New Engl J Med 328:833–838PubMedCrossRef
11.
go back to reference Prezioso D, Strazzulo P, Lotti T et al (2015) Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl 87:105–120PubMedCrossRef Prezioso D, Strazzulo P, Lotti T et al (2015) Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch Ital Urol Androl 87:105–120PubMedCrossRef
12.
go back to reference Adams F (1939) The genuine works of Hippocrates. Williams and Wilkins, Baltimore Adams F (1939) The genuine works of Hippocrates. Williams and Wilkins, Baltimore
13.
go back to reference Robertson WG (2003) A risk factor model of stone-formation. Front Biosci 8:1330–1338CrossRef Robertson WG (2003) A risk factor model of stone-formation. Front Biosci 8:1330–1338CrossRef
14.
go back to reference Power C, Barker DJ, Nelson M, Winter PD (1984) Diet and renal stones: a case–control study. Br J Urol 56:456–459PubMed Power C, Barker DJ, Nelson M, Winter PD (1984) Diet and renal stones: a case–control study. Br J Urol 56:456–459PubMed
16.
go back to reference Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105–110PubMedCrossRef Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105–110PubMedCrossRef
17.
go back to reference Robertson WG, Hughes H (1993) Importance of mild hyperoxaluria in the pathogenesis of urolithiasis—new evidence in the light of the Arabian experience. Scan Microsc 7:391–402 Robertson WG, Hughes H (1993) Importance of mild hyperoxaluria in the pathogenesis of urolithiasis—new evidence in the light of the Arabian experience. Scan Microsc 7:391–402
18.
go back to reference Erickson SB, Cooper K, Broadus AE, Smith LH, Werness PG, Binder HJ, Dobbins JW (1984) Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria. Clin Sci 67:131–138PubMedCrossRef Erickson SB, Cooper K, Broadus AE, Smith LH, Werness PG, Binder HJ, Dobbins JW (1984) Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria. Clin Sci 67:131–138PubMedCrossRef
19.
go back to reference Robertson WG, Heyburn PJ, Peacock M, Hanes F, Swaminathan R (1979) The effect of a high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 57:285–288PubMedCrossRef Robertson WG, Heyburn PJ, Peacock M, Hanes F, Swaminathan R (1979) The effect of a high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 57:285–288PubMedCrossRef
20.
go back to reference Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE (2014) Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol 29:363–369PubMedCrossRef Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE (2014) Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol 29:363–369PubMedCrossRef
21.
go back to reference Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, Maalouf N, Pak CY (2014) Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol 192:137–141PubMedCrossRef Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, Maalouf N, Pak CY (2014) Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol 192:137–141PubMedCrossRef
22.
go back to reference Massey LK, Whiting SJ (1995) Dietary salt, urinary calcium and kidney stone risk. Nutr Rev 53:131–139PubMedCrossRef Massey LK, Whiting SJ (1995) Dietary salt, urinary calcium and kidney stone risk. Nutr Rev 53:131–139PubMedCrossRef
23.
24.
go back to reference Thom JA, Morris JE, Bishop A, Blacklock NJ (1978) The influence of refined carbohydrate on urinary calcium excretion. Br J Urol 50:459–464PubMedCrossRef Thom JA, Morris JE, Bishop A, Blacklock NJ (1978) The influence of refined carbohydrate on urinary calcium excretion. Br J Urol 50:459–464PubMedCrossRef
25.
go back to reference Yasui T, Okada A, Hamamoto S, Hirose M, Ando R, Kubota Y, Tozawa K, Hayashi Y, Gao B, Suzuki S, Kohri K (2013) the association between the incidence of urolithiasis and nutrition based on Japanese national Health and Nutrition Surveys. Urolithiasis 41:217–224PubMedCrossRef Yasui T, Okada A, Hamamoto S, Hirose M, Ando R, Kubota Y, Tozawa K, Hayashi Y, Gao B, Suzuki S, Kohri K (2013) the association between the incidence of urolithiasis and nutrition based on Japanese national Health and Nutrition Surveys. Urolithiasis 41:217–224PubMedCrossRef
26.
go back to reference Reungjui S, Prasongwatana V, Premgamone A, Tosukhowong P, Jirakulsomchok S, Sriboonlue P (2002) Magnesium status of patients with renal stones and its effect on urinary citrate excretion. BJU Int 90:635–639PubMedCrossRef Reungjui S, Prasongwatana V, Premgamone A, Tosukhowong P, Jirakulsomchok S, Sriboonlue P (2002) Magnesium status of patients with renal stones and its effect on urinary citrate excretion. BJU Int 90:635–639PubMedCrossRef
27.
go back to reference Anatol TI, Pinto Pereira L, Matthew J, Sawh L (2005) The relationship of magnesium intake to serum and urinary calcium and magnesium levels in Trinidadian stone formers. In J Urol 12:244–249 Anatol TI, Pinto Pereira L, Matthew J, Sawh L (2005) The relationship of magnesium intake to serum and urinary calcium and magnesium levels in Trinidadian stone formers. In J Urol 12:244–249
28.
go back to reference Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W (2006) Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis 48:546–554PubMedCrossRef Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W (2006) Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion. Am J Kidney Dis 48:546–554PubMedCrossRef
29.
go back to reference Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316–324PubMedCrossRef Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192:316–324PubMedCrossRef
31.
go back to reference Shuster J, Finlayson B, Scheaffer R, Sierakowski R, Zoltek J, Dzegede S (1982) Water hardness and urinary stone disease. J Urol 128:422–425PubMed Shuster J, Finlayson B, Scheaffer R, Sierakowski R, Zoltek J, Dzegede S (1982) Water hardness and urinary stone disease. J Urol 128:422–425PubMed
32.
go back to reference Caudarella R, Rizzoli E, Buffa A, Bottura A, Stefoni S (1998) Comparative study on the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 159:658–663PubMedCrossRef Caudarella R, Rizzoli E, Buffa A, Bottura A, Stefoni S (1998) Comparative study on the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 159:658–663PubMedCrossRef
33.
go back to reference Schwartz BF, Schenkman NS, Bruce JE, Leslie SW, Stoller ML (2002) Calcium nephrolithiasis; effect of water hardness on urinary electrolytes. Urology 60:23–27PubMedCrossRef Schwartz BF, Schenkman NS, Bruce JE, Leslie SW, Stoller ML (2002) Calcium nephrolithiasis; effect of water hardness on urinary electrolytes. Urology 60:23–27PubMedCrossRef
34.
go back to reference Basiri A, Shakhssalim N, Khoshdel AR, Pakmanesh H, Radfar MH (2011) Drinking water composition and incidence of urinary calculus: introducing a new index. Iran J Kidney Dis 5:15–20PubMed Basiri A, Shakhssalim N, Khoshdel AR, Pakmanesh H, Radfar MH (2011) Drinking water composition and incidence of urinary calculus: introducing a new index. Iran J Kidney Dis 5:15–20PubMed
35.
go back to reference Pak CYC, Sakhaee K, Crowther C, Brinkley L (1980) Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann Intern Med 93:36–39PubMedCrossRef Pak CYC, Sakhaee K, Crowther C, Brinkley L (1980) Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann Intern Med 93:36–39PubMedCrossRef
36.
go back to reference Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–843PubMedCrossRef Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–843PubMedCrossRef
37.
go back to reference Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten MJ (2013) Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol 189:935–939PubMedCrossRef Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten MJ (2013) Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol 189:935–939PubMedCrossRef
38.
go back to reference Xu H, Zisman AL, Coe FL, Worcester EM (2013) Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother 14:435–447PubMedCentralPubMedCrossRef Xu H, Zisman AL, Coe FL, Worcester EM (2013) Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother 14:435–447PubMedCentralPubMedCrossRef
39.
go back to reference Cheungpasitporn W, Rossetti S, Friend K, Erickson SB, Lieske JC (2015) Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. doi:10.1007/s40620-015-0210-4 Cheungpasitporn W, Rossetti S, Friend K, Erickson SB, Lieske JC (2015) Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. doi:10.​1007/​s40620-015-0210-4
40.
go back to reference Ticinesi A, Nouvenne A, Borghi L, Meschi T (2015) Water and other fluids in nephrolithiasis: state of the art and future challenges. Crit Rev Food Sci Nutr (Epub ahead of print) Ticinesi A, Nouvenne A, Borghi L, Meschi T (2015) Water and other fluids in nephrolithiasis: state of the art and future challenges. Crit Rev Food Sci Nutr (Epub ahead of print)
41.
go back to reference Al-Ali IH, Husain I, Robertson WG, Ouimet E, Waheed SA (1981) Metabolic aspects of calcium oxalate urolithiasis and the effect of allopurinol. Emirates Med J 3:292–299 Al-Ali IH, Husain I, Robertson WG, Ouimet E, Waheed SA (1981) Metabolic aspects of calcium oxalate urolithiasis and the effect of allopurinol. Emirates Med J 3:292–299
43.
go back to reference Jaeger Ph, Robertson WG (2004) Role of dietary intake and intestinal absorption in calcium stone-formation. Nephron Physiol 98:64–71CrossRef Jaeger Ph, Robertson WG (2004) Role of dietary intake and intestinal absorption in calcium stone-formation. Nephron Physiol 98:64–71CrossRef
44.
go back to reference Nouvenne A, Meschi T, Guerra A, Allegri F, Prati B, Fiaccadori E, Maggiore U, Borghi L (2009) Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study. Urology 73:725–730PubMedCrossRef Nouvenne A, Meschi T, Guerra A, Allegri F, Prati B, Fiaccadori E, Maggiore U, Borghi L (2009) Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study. Urology 73:725–730PubMedCrossRef
45.
go back to reference Lange JN, Easter L, Amoroso R, Benfield D, Mufarri PW, Knight J, Holmes RP, Assimos DG (2013) Internet program for facilitating dietary modifications limiting kidney stone risk. Can J Urol 20:6922–6926PubMed Lange JN, Easter L, Amoroso R, Benfield D, Mufarri PW, Knight J, Holmes RP, Assimos DG (2013) Internet program for facilitating dietary modifications limiting kidney stone risk. Can J Urol 20:6922–6926PubMed
46.
go back to reference Marshall RW, Cochran M, Hodgkinson A (1972) Relationship between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal stone-forming subjects. Clin Sci 43:91–99PubMedCrossRef Marshall RW, Cochran M, Hodgkinson A (1972) Relationship between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal stone-forming subjects. Clin Sci 43:91–99PubMedCrossRef
47.
go back to reference Lieske JC, Tremaine WJ, De Simone C, O’Connor HM, Li X, Bergstralh EJ, Goldfarb DS (2010) Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int 78:1178–1185PubMedCentralPubMedCrossRef Lieske JC, Tremaine WJ, De Simone C, O’Connor HM, Li X, Bergstralh EJ, Goldfarb DS (2010) Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int 78:1178–1185PubMedCentralPubMedCrossRef
48.
go back to reference Terris MK, Issa MM, Tacker JR (2001) Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 57:26–29PubMedCrossRef Terris MK, Issa MM, Tacker JR (2001) Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 57:26–29PubMedCrossRef
49.
go back to reference Harris KS, Richardson KE (1980) Glycolate in the diet and its conversion to urinary oxalate in the rat. Invest Urol 18:106–109PubMed Harris KS, Richardson KE (1980) Glycolate in the diet and its conversion to urinary oxalate in the rat. Invest Urol 18:106–109PubMed
50.
go back to reference Khan SR, Glenton PA, Byer KJ (2007) Dietary oxalate and calcium oxalate nephrolithiasis. J Urol 178:2191–2196PubMedCrossRef Khan SR, Glenton PA, Byer KJ (2007) Dietary oxalate and calcium oxalate nephrolithiasis. J Urol 178:2191–2196PubMedCrossRef
51.
go back to reference Wiessner JH, Garrett MR, Hung LY, Wille DF, Mandel NS (2011) Improved methodology to induce hyperoxaluria without treatment using hydroxyproline. Urol Res 39:373–377PubMedCentralPubMedCrossRef Wiessner JH, Garrett MR, Hung LY, Wille DF, Mandel NS (2011) Improved methodology to induce hyperoxaluria without treatment using hydroxyproline. Urol Res 39:373–377PubMedCentralPubMedCrossRef
52.
53.
go back to reference Nguyen Q-V, Kälin A, Drouve U, Casez J-P, Jaeger Ph (2001) Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone-formers. Kidney Int 59:2273–2281PubMedCrossRef Nguyen Q-V, Kälin A, Drouve U, Casez J-P, Jaeger Ph (2001) Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone-formers. Kidney Int 59:2273–2281PubMedCrossRef
54.
go back to reference Marangella M, Bianco O, Martini C, Petrarulo M, Vitale C, Linari F (1989) Effect of animal and vegetable protein on oxalate excretion in idiopathic calcium stone disease. Br J Urol 63:348–351PubMedCrossRef Marangella M, Bianco O, Martini C, Petrarulo M, Vitale C, Linari F (1989) Effect of animal and vegetable protein on oxalate excretion in idiopathic calcium stone disease. Br J Urol 63:348–351PubMedCrossRef
55.
go back to reference Urivetsky M, Kessaris D, Smith AD (1992) Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 147:1215–1218 Urivetsky M, Kessaris D, Smith AD (1992) Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 147:1215–1218
56.
go back to reference Auer BL, Auer D, Rodgers AL (1998) Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 28:695–700PubMedCrossRef Auer BL, Auer D, Rodgers AL (1998) Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 28:695–700PubMedCrossRef
57.
go back to reference Traxer O, Huet B, Poindexter J, Pak CYC, Pearle MS (2003) Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397–401PubMedCrossRef Traxer O, Huet B, Poindexter J, Pak CYC, Pearle MS (2003) Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397–401PubMedCrossRef
59.
go back to reference Gerster H (1997) No contribution of ascorbic acid to renal calcium oxalate stones. Ann Nutr Metab 41:269–282PubMedCrossRef Gerster H (1997) No contribution of ascorbic acid to renal calcium oxalate stones. Ann Nutr Metab 41:269–282PubMedCrossRef
60.
go back to reference Brinkley L, McGuire J, Gregory J, Pak CYC (1981) Bioavailability of oxalate in foods. Urology 17:534–538PubMedCrossRef Brinkley L, McGuire J, Gregory J, Pak CYC (1981) Bioavailability of oxalate in foods. Urology 17:534–538PubMedCrossRef
61.
go back to reference Hossain RZ, Ogawa Y, Morozumi M, Sugaya K, Hatano T (2003) Urinary oxalic acid differs after oral loading of rats with various oxalate salts. Int J Urol 10:43–48PubMedCrossRef Hossain RZ, Ogawa Y, Morozumi M, Sugaya K, Hatano T (2003) Urinary oxalic acid differs after oral loading of rats with various oxalate salts. Int J Urol 10:43–48PubMedCrossRef
62.
go back to reference Gasińska A, Gajewska D (2007) Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones. Rocz Panstw Zakl Hig 58:61–67PubMed Gasińska A, Gajewska D (2007) Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones. Rocz Panstw Zakl Hig 58:61–67PubMed
63.
go back to reference Savage GP, Charrier MJ, Vanhanen L (2003) Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Eur J Clin Nutr 57:415–419PubMedCrossRef Savage GP, Charrier MJ, Vanhanen L (2003) Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Eur J Clin Nutr 57:415–419PubMedCrossRef
64.
go back to reference Brogren M, Savage GP (2003) Bioavailability of soluble oxalate from spinach eaten with an without milk products. Asia Pac J Nutr 12:219–224 Brogren M, Savage GP (2003) Bioavailability of soluble oxalate from spinach eaten with an without milk products. Asia Pac J Nutr 12:219–224
65.
go back to reference Earnest DL, Williams HE, Admirand WH (1975) A physicochemical basis for treatment of enteric hyperoxaluria. Trans Assoc Am Physicians 88:224–234PubMed Earnest DL, Williams HE, Admirand WH (1975) A physicochemical basis for treatment of enteric hyperoxaluria. Trans Assoc Am Physicians 88:224–234PubMed
66.
go back to reference Hylander E, Jarnum S, Nielsen K (1980) Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity. Scand J Gastroenterol 15:349–352PubMedCrossRef Hylander E, Jarnum S, Nielsen K (1980) Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity. Scand J Gastroenterol 15:349–352PubMedCrossRef
67.
go back to reference Takei K, Ito H, Masai M, Kotake T (1998) Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria. Urol Int 61:192–195PubMedCrossRef Takei K, Ito H, Masai M, Kotake T (1998) Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria. Urol Int 61:192–195PubMedCrossRef
68.
go back to reference Robertson WG, Hughes H, Husain I, Al-Faqih S, Arafat A, Chakrabarti A, Shamsuddin A, Tipton L (1994) Simultaneous treatment of calcium oxalate and uric acid stone disease in Saudi Arabia. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum Press, New York, pp 581–586CrossRef Robertson WG, Hughes H, Husain I, Al-Faqih S, Arafat A, Chakrabarti A, Shamsuddin A, Tipton L (1994) Simultaneous treatment of calcium oxalate and uric acid stone disease in Saudi Arabia. In: Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum Press, New York, pp 581–586CrossRef
69.
go back to reference Rodgers AL, Allie-Hamdulay S, Jackson GE, Sutton RA (2014) Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols. J Endourol 28:985–994PubMedCrossRef Rodgers AL, Allie-Hamdulay S, Jackson GE, Sutton RA (2014) Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols. J Endourol 28:985–994PubMedCrossRef
70.
go back to reference Gleeson MJ, Thompson AS, Mehta S, Griffith DP (1990) Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis. Urology 35:231–234PubMedCrossRef Gleeson MJ, Thompson AS, Mehta S, Griffith DP (1990) Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis. Urology 35:231–234PubMedCrossRef
71.
go back to reference Hanson CF, Frankos VH, Thompson WO (1989) Bioavailability of oxalic acid from spinach, sugar beet fibre and a solution of sodium oxalate consumed by female volunteers. Food Chem Toxicol 27:181–184PubMedCrossRef Hanson CF, Frankos VH, Thompson WO (1989) Bioavailability of oxalic acid from spinach, sugar beet fibre and a solution of sodium oxalate consumed by female volunteers. Food Chem Toxicol 27:181–184PubMedCrossRef
72.
go back to reference Hatch M, Freel RW, Vaziri ND (1994) Mechanisms of oxalate absorption and secretion across the rabbit distal colon. Pflügers Arch 426:101–109PubMedCrossRef Hatch M, Freel RW, Vaziri ND (1994) Mechanisms of oxalate absorption and secretion across the rabbit distal colon. Pflügers Arch 426:101–109PubMedCrossRef
73.
go back to reference Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–7PubMedCrossRef Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–7PubMedCrossRef
74.
go back to reference Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481PubMedCrossRef Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475–481PubMedCrossRef
75.
go back to reference Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD (2002) Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41:318–322PubMedCrossRef Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD (2002) Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 41:318–322PubMedCrossRef
76.
go back to reference Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176PubMedCrossRef Troxel SA, Sidhu H, Kaul P, Low RK (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173–176PubMedCrossRef
77.
go back to reference Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H (2003) Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 10:293–296PubMedCrossRef Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H (2003) Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 10:293–296PubMedCrossRef
78.
go back to reference Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A (2013) The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 83:1144–1149PubMedCrossRef Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A (2013) The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 83:1144–1149PubMedCrossRef
79.
go back to reference Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105PubMedCrossRef Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097–1105PubMedCrossRef
80.
go back to reference Stewart CS, Duncan SH, Cave DR (2004) Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol Lett 230:1–7PubMedCrossRef Stewart CS, Duncan SH, Cave DR (2004) Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol Lett 230:1–7PubMedCrossRef
81.
go back to reference Nordin BEC, Barry H, Bulusu L, Speed R (1973) Dietary treatment of recurrent calcium stone disease. In: Rapado A, Hodgkinson A, Cifuentes Delatte L (eds) Urinary calculi. Karger, Basel, pp 170–176 Nordin BEC, Barry H, Bulusu L, Speed R (1973) Dietary treatment of recurrent calcium stone disease. In: Rapado A, Hodgkinson A, Cifuentes Delatte L (eds) Urinary calculi. Karger, Basel, pp 170–176
82.
go back to reference Messa P, Marangella M, Paganin L, Codardini M, Cruciatti A, Turrin D, Filiberto Z, Mioni G (1997) Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones. Clin Sci 93:257–263PubMedCrossRef Messa P, Marangella M, Paganin L, Codardini M, Cruciatti A, Turrin D, Filiberto Z, Mioni G (1997) Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones. Clin Sci 93:257–263PubMedCrossRef
83.
go back to reference Willis S, Thomas K (2010) Do oral calcium supplements increase the risk of urolithiasis? BJU Int 106:155–159PubMedCrossRef Willis S, Thomas K (2010) Do oral calcium supplements increase the risk of urolithiasis? BJU Int 106:155–159PubMedCrossRef
84.
go back to reference Sedrani SH (1984) Low 25-hydroxy vitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab 28:181–185PubMedCrossRef Sedrani SH (1984) Low 25-hydroxy vitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab 28:181–185PubMedCrossRef
85.
go back to reference Goldfarb DS (2009) Prospects for dietary therapy of recurrent urolithiasis. Adv Chronic Kidney Dis 16:21–29PubMedCrossRef Goldfarb DS (2009) Prospects for dietary therapy of recurrent urolithiasis. Adv Chronic Kidney Dis 16:21–29PubMedCrossRef
86.
go back to reference Sorensen MD, Kahn AJ, Reiner AP et al (2012) Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol 187:1645–1649PubMedCentralPubMedCrossRef Sorensen MD, Kahn AJ, Reiner AP et al (2012) Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol 187:1645–1649PubMedCentralPubMedCrossRef
87.
go back to reference Hess B, Jost C, Zipperle L, Takkinen R, Jaeger Ph (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241–2247PubMedCrossRef Hess B, Jost C, Zipperle L, Takkinen R, Jaeger Ph (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241–2247PubMedCrossRef
88.
go back to reference Siener R, Jahnen A, Hesse A (2004) Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 58:270–276PubMedCrossRef Siener R, Jahnen A, Hesse A (2004) Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 58:270–276PubMedCrossRef
89.
go back to reference Robertson WG (2015) Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall’s Plugs and calcium oxalate crystalluria in a computer model of renal function. Urolithiasis 43(Suppl 1):S93–S107CrossRef Robertson WG (2015) Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall’s Plugs and calcium oxalate crystalluria in a computer model of renal function. Urolithiasis 43(Suppl 1):S93–S107CrossRef
90.
go back to reference Basiri A, Shakhssalim N, Khoshdel AR, Radfar MH, Pakmanesh H (2009) Influential nutrient in urolithiasis incidence: protein or meat? J Ren Nutr 19:396–400PubMedCrossRef Basiri A, Shakhssalim N, Khoshdel AR, Radfar MH, Pakmanesh H (2009) Influential nutrient in urolithiasis incidence: protein or meat? J Ren Nutr 19:396–400PubMedCrossRef
91.
go back to reference Caldwell EF, Mayor LR, Thomas MG, Danpure CJ (2004) Diet and the frequency of the alanine:glyoxylate aminotransferase PRO11Leu polymorphism in different human populations. Hum Genet 115:504–509PubMedCrossRef Caldwell EF, Mayor LR, Thomas MG, Danpure CJ (2004) Diet and the frequency of the alanine:glyoxylate aminotransferase PRO11Leu polymorphism in different human populations. Hum Genet 115:504–509PubMedCrossRef
92.
go back to reference Knight J, Easter LH, Neiberg R, Assimos DG, Holmes RP (2009) Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion. Urol Res 37:63–68PubMedCentralPubMedCrossRef Knight J, Easter LH, Neiberg R, Assimos DG, Holmes RP (2009) Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion. Urol Res 37:63–68PubMedCentralPubMedCrossRef
93.
go back to reference Barkworth SA, Louis S, Walker VR, Hughes H, Robertson WG (1989) Stone type and urine composition in the Middle East with particular reference to Saudi Arabia. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 715CrossRef Barkworth SA, Louis S, Walker VR, Hughes H, Robertson WG (1989) Stone type and urine composition in the Middle East with particular reference to Saudi Arabia. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds) Urolithiasis. Plenum Press, New York, p 715CrossRef
94.
go back to reference Robertson WG, Peacock M, Heyburn PJ, Hanes F, Rutherford A, Clementson E, Swaminathan R, Clark PB (1979) Should recurrent, calcium-containing stone-formers become vegetarians? Br J Urol 51:427–431PubMedCrossRef Robertson WG, Peacock M, Heyburn PJ, Hanes F, Rutherford A, Clementson E, Swaminathan R, Clark PB (1979) Should recurrent, calcium-containing stone-formers become vegetarians? Br J Urol 51:427–431PubMedCrossRef
95.
go back to reference Siener R, Hesse A (2003) The effect of vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation. Eur J Nutr 42:332–337PubMedCrossRef Siener R, Hesse A (2003) The effect of vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation. Eur J Nutr 42:332–337PubMedCrossRef
96.
go back to reference Robertson WG, Peacock M, Marshall DH (1982) Prevalence of urinary stone disease in vegetarians. Eur Urol 8:334–339PubMed Robertson WG, Peacock M, Marshall DH (1982) Prevalence of urinary stone disease in vegetarians. Eur Urol 8:334–339PubMed
97.
go back to reference Sorensen MD, His RS, Chi T et al (2014) Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women’s Health Initiative report. J Urol 192:1694–1699PubMedCentralPubMedCrossRef Sorensen MD, His RS, Chi T et al (2014) Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women’s Health Initiative report. J Urol 192:1694–1699PubMedCentralPubMedCrossRef
98.
go back to reference Giannini S, Nobile M, Sartori L et al. (1999) Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 69:267–271PubMed Giannini S, Nobile M, Sartori L et al. (1999) Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 69:267–271PubMed
99.
go back to reference Rotily M, Léonetti F, Iovanna C, Berthezene P, Dupuy P, Vazi A, Berland Y (2000) Effects of low animal protein or high-fiber diets on urine composition in calcium nephrolithiasis. Kidney Int 57:1115–1123PubMedCrossRef Rotily M, Léonetti F, Iovanna C, Berthezene P, Dupuy P, Vazi A, Berland Y (2000) Effects of low animal protein or high-fiber diets on urine composition in calcium nephrolithiasis. Kidney Int 57:1115–1123PubMedCrossRef
100.
go back to reference Borghi L, Schianci T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. New Engl J Med 346:77–84PubMedCrossRef Borghi L, Schianci T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. New Engl J Med 346:77–84PubMedCrossRef
101.
go back to reference Van Den Berg CJ, Kumar R, Wilson DM, Heath H 3rd, Smith LH (1980) Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxy vitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 51:998–1001CrossRef Van Den Berg CJ, Kumar R, Wilson DM, Heath H 3rd, Smith LH (1980) Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxy vitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 51:998–1001CrossRef
102.
go back to reference Heyburn PJ, Robertson WG, Peacock M (1982) Phosphate treatment of recurrent calcium stone disease. Nephron 32:314–319PubMedCrossRef Heyburn PJ, Robertson WG, Peacock M (1982) Phosphate treatment of recurrent calcium stone disease. Nephron 32:314–319PubMedCrossRef
103.
go back to reference Fleisch H, Bisaz S (1962) Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 203:671–675PubMed Fleisch H, Bisaz S (1962) Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol 203:671–675PubMed
104.
go back to reference Fleisch H, Bisaz S (1964) The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis. Experientia 20:276–277PubMedCrossRef Fleisch H, Bisaz S (1964) The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis. Experientia 20:276–277PubMedCrossRef
105.
go back to reference Ettinger B (1976) Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study. Am J Med 61:200–206PubMedCrossRef Ettinger B (1976) Recurrent nephrolithiasis: natural history and effect of phosphate therapy. A double-blind controlled study. Am J Med 61:200–206PubMedCrossRef
106.
go back to reference Johansson G, Backman U, Danielson BG, Fellström B, Ljunghall S, Wikström B (1980) Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124:770–774PubMed Johansson G, Backman U, Danielson BG, Fellström B, Ljunghall S, Wikström B (1980) Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol 124:770–774PubMed
107.
go back to reference Lindberg J, Harvey J, Pak CYC (1990) Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction. J Urol 143:248–251PubMed Lindberg J, Harvey J, Pak CYC (1990) Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction. J Urol 143:248–251PubMed
108.
go back to reference Zerwekh JE, Odvina CV, Wuermser LA, Pak CY (2007) Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol 177:2179–2184PubMedCrossRef Zerwekh JE, Odvina CV, Wuermser LA, Pak CY (2007) Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol 177:2179–2184PubMedCrossRef
109.
go back to reference Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM Jr (2012) High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis. Urology 80:780–783PubMedCrossRef Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM Jr (2012) High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis. Urology 80:780–783PubMedCrossRef
110.
go back to reference Simpson DP (1967) Regulation of renal citrate metabolism by bicarbonate ion and pH: observations in tissue slices and mitochondria. J Clin Invest 46:225–238PubMedCentralPubMedCrossRef Simpson DP (1967) Regulation of renal citrate metabolism by bicarbonate ion and pH: observations in tissue slices and mitochondria. J Clin Invest 46:225–238PubMedCentralPubMedCrossRef
111.
go back to reference Pak CY, Sakhaee K, Fuller CJ (1983) Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Trans Assoc Am Physicians 96:294–305PubMed Pak CY, Sakhaee K, Fuller CJ (1983) Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Trans Assoc Am Physicians 96:294–305PubMed
112.
go back to reference Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761–1764PubMed Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761–1764PubMed
113.
go back to reference Jendle-Bengten C, Tiselius HG (2000) Long-term follow-up of stone-formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34:36–41PubMedCrossRef Jendle-Bengten C, Tiselius HG (2000) Long-term follow-up of stone-formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34:36–41PubMedCrossRef
114.
115.
go back to reference Coe FL, Evan A, Worcester EM (2011) Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6:2083–2092PubMedCrossRef Coe FL, Evan A, Worcester EM (2011) Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6:2083–2092PubMedCrossRef
116.
go back to reference Mandel EI, Taylor EN, Curhan GC (2013) Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol 8:901–908PubMedCentralPubMedCrossRef Mandel EI, Taylor EN, Curhan GC (2013) Dietary and lifestyle factors and medical conditions associated with urinary citrate excretion. Clin J Am Soc Nephrol 8:901–908PubMedCentralPubMedCrossRef
117.
go back to reference Kohjimoto Y, Sasaki Y, Iguchi M, Inagaki T, Hara I (2013) Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis 61:923–929PubMedCrossRef Kohjimoto Y, Sasaki Y, Iguchi M, Inagaki T, Hara I (2013) Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis 61:923–929PubMedCrossRef
118.
go back to reference Robertson WG, Nair D, Laing C, Choong S, Jaeger P, Unwin RJ (2008) The role of “Metabolic Syndrome” in the formation of uric acid-containing stones. Urol Res 36:177–178 Robertson WG, Nair D, Laing C, Choong S, Jaeger P, Unwin RJ (2008) The role of “Metabolic Syndrome” in the formation of uric acid-containing stones. Urol Res 36:177–178
120.
go back to reference Weaver CM, Heaney RP, Martin BR, Fitzsimmons ML (1991) Human calcium absorption from whole-wheat products. J Nutr 121:1769–1775PubMed Weaver CM, Heaney RP, Martin BR, Fitzsimmons ML (1991) Human calcium absorption from whole-wheat products. J Nutr 121:1769–1775PubMed
121.
go back to reference Nouvenne A, Meschi T, Prati B et al (2010) Effects of a low-salt diet on idiopathic hypercalciuria in calcium oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr 91:565–570PubMedCrossRef Nouvenne A, Meschi T, Prati B et al (2010) Effects of a low-salt diet on idiopathic hypercalciuria in calcium oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr 91:565–570PubMedCrossRef
122.
go back to reference Barilla DE, Townsend J, Pak CYC (1978) An exaggerated augmentation of renal calcium excretion after oral glucose in patients with renal hypercalciuria. Invest Urol 15:486–488PubMed Barilla DE, Townsend J, Pak CYC (1978) An exaggerated augmentation of renal calcium excretion after oral glucose in patients with renal hypercalciuria. Invest Urol 15:486–488PubMed
123.
go back to reference Rao PN, Prendiville V, Buxton A, Moss DG, Blacklock NJ (1982) Dietary management of urinary risk factors in renal stone formers. Br J Urol 54:578–583PubMedCrossRef Rao PN, Prendiville V, Buxton A, Moss DG, Blacklock NJ (1982) Dietary management of urinary risk factors in renal stone formers. Br J Urol 54:578–583PubMedCrossRef
124.
go back to reference Remer T, Manz F (1995) Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc 95:791–797PubMedCrossRef Remer T, Manz F (1995) Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc 95:791–797PubMedCrossRef
125.
go back to reference Trinchieri A, Maletta A, Lizzano R, Marchesotti F (2013) Potential renal acid load and the risk of renal stone formation in case–control study. Eur J Clin Nutr 67:1077–1080PubMedCrossRef Trinchieri A, Maletta A, Lizzano R, Marchesotti F (2013) Potential renal acid load and the risk of renal stone formation in case–control study. Eur J Clin Nutr 67:1077–1080PubMedCrossRef
126.
go back to reference Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years follow-up. J Am Soc Nephrol 15:3225–3232PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years follow-up. J Am Soc Nephrol 15:3225–3232PubMedCrossRef
129.
go back to reference Noori N, Honarker E, Goldfarb DS et al (2014) Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis 63:456–463PubMedCrossRef Noori N, Honarker E, Goldfarb DS et al (2014) Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets. Am J Kidney Dis 63:456–463PubMedCrossRef
130.
go back to reference Robertson WG (1998) The medical management of urinary stone disease. Eur Urol Update Series 7:139–144 Robertson WG (1998) The medical management of urinary stone disease. Eur Urol Update Series 7:139–144
131.
go back to reference Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten MJ (2012) Primary prevention of nephrolithiasis is cost-effective for a national healthcare system. BJU Int 110:E1060–E1067PubMedCrossRef Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten MJ (2012) Primary prevention of nephrolithiasis is cost-effective for a national healthcare system. BJU Int 110:E1060–E1067PubMedCrossRef
132.
go back to reference Norman RW, Bath SS, Robertson WG, Peacock M (1984) When should patients with symptomatic stone disease be evaluated metabolically? J Urol 132:1137–1139PubMed Norman RW, Bath SS, Robertson WG, Peacock M (1984) When should patients with symptomatic stone disease be evaluated metabolically? J Urol 132:1137–1139PubMed
133.
go back to reference Robertson WG (2011) Establishment and management of a stone clinic. In: Rao NP, Preminger GM, Kavanagh JP (eds) Urinary tract stone disease. Springer, London, pp 641–650 Robertson WG (2011) Establishment and management of a stone clinic. In: Rao NP, Preminger GM, Kavanagh JP (eds) Urinary tract stone disease. Springer, London, pp 641–650
Metadata
Title
Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease
Author
W. G. Robertson
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 1/2016
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-015-0849-2

Other articles of this Issue 1/2016

Urolithiasis 1/2016 Go to the issue